Meet Parmar

Meet Parmar

Active Director Director DIN 09338755
DIN 09338755 First appointment Sep 2021 Primary industry Professional Services
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Meet Parmar

Data last updated:

Meet Parmar is a Director at Vishvakarma Chem & Pharma Private Limited (since 2021). The company operates in Professional Services. Vishvakarma Chem & Pharma Private Limited reported revenue of ₹20.5 Lakh (FY 2024).

DIN 09338755
Primary Designation Director
Industry Professional Services
First Appointment 29 Sep 2021
Oldest Company Age 5 yrs
Largest company Vishvakarma Chem & Pharma Private Limited · ₹20.5 Lakh (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Sep 20212021₹20.5 Lakh (FY 2024)Active

Board colleagues of Meet Parmar

Directorship timeline

Open interactive timeline →
Vishvakarma Chem & Pharma Private Limited
Premium access

Shareholding and investment profile for Meet Parmar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Meet Parmar

Meet Parmar currently holds 1 directorship: Vishvakarma Chem & Pharma Private Limited (Director, since 29 Sep 2021, revenue ₹20.5 Lakh (FY 2024)).

Meet Parmar was first appointed on 29 Sep 2021 as Director at Vishvakarma Chem & Pharma Private Limited.

The current boards of Meet Parmar's companies include Dakshaben Kalpeshbhai Sidhhpura (Vishvakarma Chem & Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available